Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en cartouche - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - il diabete mellito - biotechnologika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - amisulpridum - gocce orali - amisulpridum 100 mg, acidum hydrochloricum q.s. ad ph, aromatica, saccharinum natricum, natrii gluconas, d-glucono-1,5-lactonum, e 202, propylis parahydroxybenzoas 0.5 mg, e 218 1 mg, aqua purificata ad solutionem pro 1 ml corresp. natrium 3.7 mg. - neuroleptique - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - ambroxoli hydrochloridum - comprimés à sucer (arôme cassis et menthol) - ambroxoli hydrochloridum 20 mg, aromatica (arôme cassis et menthol), sucralosum, sorbitolum 1381.0 mg, macrogolum 6000, talcum, pro compresso. - mal di gola - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

ge healthcare ag - ioflupanum(123 i) per kalibrierungszeitpunkt - soluzione iniettabile - ioflupanum(123-i) zum kalibrierungszeitpunkt 185 mbq, ioflupanum(127-i), ethanolum 100 mg, acidum aceticum, natrii acetas trihydricus corresp. natrium 3.29 mg, aqua ad iniectabile, q.s. ad solutionem pro 2.5 ml. - indagine dopaminerger neuronenendigungen nello striato di pazienti clinicamente poco chiare malattia di parkinson sintomi - radiopharmazeutika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - sevelameri hydrochloridum - compresse rivestite con film - sevelameri hydrochloridum 800 mg, silica colloidalis anhydrica, acidum stearicum, aqua purificata, pellicule: hypromellosum, monoglyceriderorum diacetylates, pro compresso obducto. - il trattamento dell'iperfosfatemia in pazienti adulti in emodialisi o dialisi peritoneale - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - insulinum glulisinum - soluzione iniettabile - insulinum glulisinum 3.49 mg corresp. insulinum glulisinum 100 u., metacresolum, trometamolum, natrii chloridum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml corresp. natrium 1.97 mg. - il diabete mellito in adulti - biotechnologika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - zolpidemi tartras - compresse a rilascio controllato - zolpidemi tartras 6.25 mg, lactosum monohydricum 138,9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hypromellosum, magnesii stearas, silica colloidalis anhydrica, kalii hydrogenotartras, macrogolum 3350, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium max. 0.25 mg. - ipnotico - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - zolpidemi tartras - compresse a rilascio controllato - zolpidemi tartras 12.5 mg, lactosum monohydricum 138.9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hypromellosum, magnesii stearas, silica colloidalis anhydrica, kalii hydrogenotartras, macrogolum 3350, e 132, e 171, e 172 (flavum), pro compresso obducto corresp. natrium max. 0.25 mg. - ipnotico - synthetika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - insulinum glarginum - soluzione iniettabile - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - il diabete mellito - biotechnologika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - insulinum glulisinum - soluzione iniettabile - insulinum glulisinum 3.49 mg corresp. insulinum glulisinum 100 u., trometamolum, natrii chloridum, polysorbatum 20, conserv.: metacresolum 3.15 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - il diabete mellito in adulti - biotechnologika